SART1 293T Cell Transient Overexpression Lysate(Denatured)

Catalog # H00009092-T01

Size

Price

Stock

Quantity

Size:100 uL
Price: USD $ 247.00
Stock:
order now, ship in 6 weeks
abnova-minus
abnova-plus

* The price is valid only in USA. Please select country.

Contact Info
  • +1-909-264-1399
    +1-909-992-0619
    Toll Free : +1-877-853-6098
  • +1-909-992-3401
Images
SDS-PAGE Gel
QC Test

SDS-PAGE Gel

SART1 transfected lysate.

Western Blot
QC Test

Western Blot

Lane 1: SART1 transfected lysate ( 88.11 KDa)
Lane 2: Non-transfected lysate.

  • Specification

    Transfected Cell Line

    293T

    Plasmid

    pCMV-SART1 full-length

    Host

    Human

    Theoretical MW (kDa)

    88.11

    Interspecies Antigen Sequence

    Mouse (94); Rat (94)

    Quality Control Testing

    Transient overexpression cell lysate was tested with Anti-SART1 antibody (H00009092-B01) by Western Blots.

    SDS-PAGE Gel

    SART1 transfected lysate.

    Western Blot

    Lane 1: SART1 transfected lysate ( 88.11 KDa)
    Lane 2: Non-transfected lysate.

    Storage Buffer

    1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)

    Storage Instruction

    Store at -80°C. Aliquot to avoid repeated freezing and thawing.

  • Applications

    Western Blot

  • Gene Info — SART1

    Entrez GeneID

    9092

    GeneBank Accession#

    NM_005146.3

    Protein Accession#

    NP_005137.1

    Gene Name

    SART1

    Gene Alias

    Ara1, HOMS1, MGC2038, SART1259, SNRNP110, Snu66

    Gene Description

    squamous cell carcinoma antigen recognized by T cells

    Omim ID

    605941

    Gene Ontology

    Hyperlink

    Gene Summary

    This gene encodes two proteins, the SART1(800) protein expressed in the nucleus of the majority of proliferating cells, and the SART1(259) protein expressed in the cytosol of epithelial cancers. The SART1(259) protein is translated by the mechanism of -1 frameshifting during posttranscriptional regulation; its full-length sequence is not published yet. The two encoded proteins are thought to be involved in the regulation of proliferation. Both proteins have tumor-rejection antigens. The SART1(259) protein possesses tumor epitopes capable of inducing HLA-A2402-restricted cytotoxic T lymphocytes in cancer patients. This SART1(259) antigen may be useful in specific immunotherapy for cancer patients and may serve as a paradigmatic tool for the diagnosis and treatment of patients with atopy. The SART1(259) protein is found to be essential for the recruitment of the tri-snRNP to the pre-spliceosome in the spliceosome assembly pathway. [provided by RefSeq

    Other Designations

    IgE autoantigen|SART1(259) protein|SART1(800) protein|U4/U6.U5 tri-snRNP-associated 110 kDa protein|small nuclear ribonucleoprotein 110kDa (U4/U6.U5)|squamous cell carcinoma antigen recognised by T cells|squamous cell carcinoma antigen recognized by T cel

  • Interactome
  • Disease
Contact Info
  • +1-909-264-1399
    +1-909-992-0619
    Toll Free : +1-877-853-6098
  • +1-909-992-3401
4 Products to Compare
Remove All